ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
16,867.60
-0.80%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.275
0.06%
Bitcoin
64,223.99
-0.09%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aileron Therapeutics Inc (ALRN) Quote

Aileron Therapeutics Inc

Aileron Therapeutics Inc (ALRN)

NASDAQ
4.93
0.14
(2.92%)
Closed April 25 4:00PM
Delayed by 15 minutes
4.93
0.00
(0.00%)
After Hours: 5:54PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.93
Bid
4.70
Ask
5.20
Volume
102,254
4.65 Day's Range 4.93
1.01 52 Week Range 7.42
Market Cap
24.086M
Previous Close
4.79
Open
4.88
Last Trade
4
@
4.95
Last Trade Time
Financial Volume
$ 490,317
VWAP
4.7951
Average Volume (3m)
65,430
Shares Outstanding
4,885,512
Dividend Yield
-
PE Ratio
-0.88
Earnings Per Share (EPS)
-5.59
Revenue
-
Net Profit
-27.33M

About Aileron Therapeutics Inc

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aileronrx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aileron Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALRN. The last closing price for Aileron Therapeutics was $4.79. Over the last year, Aileron Therapeutics shares have traded in a share price range of $ 1.01 to $ 7.42.

Aileron Therapeutics currently has 4,885,512 shares outstanding. The market capitalization of Aileron Therapeutics is $24.09 million. Aileron Therapeutics has a price to earnings ratio (PE ratio) of -0.88.

ALRN Latest News

More News

Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Topline results from Phase 1b study of LTI-03, a novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected to be reported in the third quarter of...

April 15 2024
GlobeNewswire Inc.

Aileron Therapeutics Announces CEO Transition

Current President and Chief Operating Officer, Brian Windsor, Ph.D., appointed Chief Executive Officer Dr. Windsor to lead Aileron into a new era focused on advancing a pipeline of first-in-class...

March 12 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

March 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 29 2024
Edgar (US Regulatory)

Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event

WALTHAM, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to...

February 15 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 13 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

February 06 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 05 2024
Edgar (US Regulatory)

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to...

February 01 2024
GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

January 31 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.15-2.952755905515.087.424.124168194.9455732CS
4-0.73-12.89752650185.667.424.121480545.2365111CS
120.439.555555555564.57.423.93654305.20101CS
263.61273.4848484851.327.421.011002193.96507454CS
523.43228.6666666671.57.421.01584463.62279075CS
156-20.87-80.891472868225.8281.0132531311.3372417CS
260-29.47-85.668604651234.449.41.0162467522.876145CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.43
(182.34%)
220.51M
AIREreAlpha Tech Corporation
$ 1.14
(88.74%)
35.42M
BOFBranchOut Food Inc
$ 2.0144
(72.17%)
107.44M
LICNLichen China Limited
$ 0.94
(67.86%)
15.08M
AMSTAmesite Inc
$ 3.31
(65.50%)
70.3M
NCINeo Concept International Group Holdings Ltd
$ 2.33
(-75.47%)
8.33M
GCTKGlucoTrack Inc
$ 0.466
(-38.68%)
1.7M
ISUNiSun Inc
$ 0.0922
(-38.12%)
9.79M
VAXXVaxxinity Inc
$ 0.1326
(-33.70%)
4.95M
EVOEvotec SE
$ 5.2199
(-31.77%)
1.55M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.43
(182.34%)
220.51M
TSLATesla Inc
$ 162.13
(12.06%)
181.24M
SQQQProShares UltraPro Short QQQ
$ 11.81
(-0.84%)
148.21M
BOFBranchOut Food Inc
$ 2.0144
(72.17%)
107.44M
NKLANikola Corporation
$ 0.6206
(-2.31%)
80.82M

ALRN Discussion

View Posts
Monksdream Monksdream 3 weeks ago
ALRN 10Q due 4/2
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
ALRN....WEEKLY BREAK OUT BIO BEAST
👍️0
Monksdream Monksdream 1 month ago
ALRN 10Q due 3/26
👍️0
Monksdream Monksdream 1 month ago
ALRN 10Q /19
👍️0
Prominent Capital Prominent Capital 4 months ago
Something is coming up
👍️0
glenn1919 glenn1919 5 months ago
ALRN...............................https://stockcharts.com/h-sc/ui?s=ALRN&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 months ago
ALRN under $2
👍️0
ErnieBilco ErnieBilco 1 year ago
Ending development - cutting staff and looking for any way out - appears BK is coming soon.
👍️0
Emerging Growth Conf Emerging Growth Conf 2 years ago
$ALRN Presenting Live on the Emerging Growth Conference 1/5/22

Register here to interact lie with the Company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167336458
👍️0
boston127 boston127 3 years ago
Straight RED the past 6 months.

Doesn't look promising, but showing life this AM.
👍️0
jerseyboy jerseyboy 3 years ago
I like this at the current price level. This could be as good or better than GTHX. I'm in on Monday morning.
👍️0
jerseyboy jerseyboy 3 years ago
They're bullish here because Aileron's drug has the potential to be bigger than GTHX's is going to be, and they just got FDA approval to start the whole chemoprotection industry off and give it validation. If they can get this through the trials and get approval, this is a $100 stock. I'll be buying all I can over the next couple of years. This will not be at $2.00 for very long.
👍️0
Phd11 Phd11 3 years ago
Nice last couple of days
👍️0
Phd11 Phd11 3 years ago
Any particular reason why you think it will break out now? Isn’t this more of a longer haul?
👍️0
TrendTrade2016 TrendTrade2016 3 years ago
ready to break out
👍️0
Sainghip Sainghip 3 years ago
I think we might see $2.50 $ALRN$
👍️0
ClayTrader ClayTrader 3 years ago
* * $ALRN Video Chart 01-11-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
stupidRICHxASAP stupidRICHxASAP 3 years ago
The offering is at $1.10 , why are people bullish here?
👍️0
TrendTrade2016 TrendTrade2016 3 years ago
ALRN boom gappa!!!!
👍️0
ClayTrader ClayTrader 3 years ago
* * $ALRN Video Chart 01-05-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
fekk fekk 3 years ago
Something knows someone.
👍️0
ddavis10 ddavis10 3 years ago
What is going on this morning
👍️0
Briboy Briboy 3 years ago
Look at the 6 month chart.

Very unusual but pretty clear when this
one makes its mark. I have loaded up,
finally see the share price increase by
about 5%

$1.05/share

Keep goin ALRN

Briboy

________________________________________
👍️0
akamaii akamaii 4 years ago
When is you’re time frame
👍️0
Sainghip Sainghip 4 years ago
Going to $5 soon IMHO
👍️0
Briboy Briboy 4 years ago
CT: Am interested to see what you have

to say here. This lacks volume right now
but other indicators suggest the share price
is moving up. I've flipped once, but after
this no longer a candidate due to low volume.

You're da best sir.

Briboy
[Thomas]
👍️0
ClayTrader ClayTrader 4 years ago
* * $ALRN Video Chart 08-05-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Doubledown22 Doubledown22 4 years ago
The stock’s chart is broke af now though isn’t it?? Melted through “that purple line” SMA like it didn’t exist at all in pure Pump and Dump style. There’s an old I-Hub saying that once ClayTrader does a chart on it you better sell immediately because the pps is sure to head south very soon afterwards. Lol Great for shorts to follow though for leads to trade on. ????

All IMO,

DD22
👍️0
ClayTrader ClayTrader 4 years ago
* * $ALRN Video Chart 05-29-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $ALRN Video Chart 05-28-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
anthjr87 anthjr87 4 years ago
Guess again buddy
👍️0
edwardport edwardport 4 years ago
chart indicates further declines
👍️0
ClayTrader ClayTrader 4 years ago
* * $ALRN Video Chart 11-04-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Glider549 Glider549 4 years ago
OMG!
WOW!
👍️0
Glider549 Glider549 4 years ago
Looking good today.
👍️0
Hunkachunk Hunkachunk 4 years ago
WATERTOWN, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides, today announced that the Company will host a conference call and webcast at 8:30 a.m. ET on Thursday, November 7, 2019 to report its third quarter 2019 financial results and provide a corporate update.
👍️0
Glider549 Glider549 4 years ago
Positive news and info.

https://www.globenewswire.com/news-release/2019/10/29/1936963/0/en/Aileron-Therapeutics-Announces-Positive-Nonclinical-Myelopreservation-Results-for-ALRN-6924-at-the-2019-AACR-NCI-EORTC-Conference.html
👍️0
ClayTrader ClayTrader 5 years ago
* * $ALRN Video Chart 10-22-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
MARINO MARINO 5 years ago
I'm in. All Aboard
👍️0
buypumps buypumps 5 years ago
News pure lotto ticket. Could be a runner Monday! 27 Million shares out. Low float. Nasdaq deficient, OPEN PROSPECTUS CURRENTLY See what pre-market looks like.
News was positive though.
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
ALRN~~up north reversal
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
ALRT huge oversold
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
ALRN .50/.52
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
ALRN~~.445 52 whlow today,better buy now,next news could be huge
👍️0
ClayTrader ClayTrader 5 years ago
* * $ALRN Video Chart 01-16-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
yankees18 yankees18 5 years ago
took some
👍️0

Your Recent History

NASDAQ
ALRN
Aileron Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved